Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ACEDUCT Trial
NCT05340582Phase 2Recruiting
- Sponsor
- Mount Sinai Hospital
- Start
- Dec 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of acetaminophen in patent ductus arteriosus (PDA), sponsored by Mount Sinai Hospital. Started Dec 2022; status: recruiting.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT05340582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340582.